Bank of Montreal’s Imunon IMNN Stock Holding History

Bank of Montreal’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	–	–	4254
2021 Q1	$0	Hold	1	–	–	﹤0.01%	5206
2020 Q4	$0	Hold	1	–	–	﹤0.01%	5027
2020 Q3	$0	Hold	1	–	–	﹤0.01%	4843
2020 Q2	$0	Buy	+1	New	+$434	﹤0.01%	4718

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's IMNN Position: Q2 2021 in Review

Bank of Montreal sold out of Imunon (IMNN) in Q2 2021, closing a stake of 1 share.

Bank of Montreal first reported a position in IMNN in Q2 2020 and held it in 4 quarters. The position peaked at $0 in Q1 2021. 37 funds tracked by Wall St. Rank hold IMNN as of Q2 2021.

Bank of Montreal reported no remaining Imunon position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 1 Imunon share in Q2 2021.
Bank of Montreal first reported a position in Imunon in Q2 2020 and held it in 4 quarters.
Bank of Montreal's Imunon position peaked at $0 in Q1 2021.
37 funds tracked by Wall St. Rank held Imunon as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.